Is Colgate-Palmolive Stock Underperforming the Dow?
Colgate-Palmolive (CL) is down about 11.1% from its Feb. 27 52-week high of $99.33 and has fallen 9.3% over three months versus the Dow’s 4.9% gain, though it is up 11.7% YTD versus the index’s 6.8%. After its May 1 Q1 2026 report, revenue rose 8.4% to $5.3B and adjusted EPS rose to $0.97. Analysts rate it “Moderate Buy” with a $95.16 mean target.
CL is positioned as a relative laggard despite a recent earnings beat and technical strength above key moving averages.
Article frames Colgate-Palmolive’s relative underperformance versus the Dow while citing its better-than-expected Q1 2026 results and moving-average trend.
Near-term trading likely hinges on whether investors re-rate CL versus the Dow; absent new guidance, impact should be modest.
Background
The article compares CL’s recent and longer-term performance versus the Dow and notes a May 1 earnings beat (Q1 2026) with revenue and adjusted EPS above expectations.
Why it matters
Relative underperformance could attract mean-reversion or defensive re-rating trades, but the lack of new company-specific developments limits immediate repricing catalysts.
Market relevance
Traders get a relative-performance and technical snapshot for CL, anchored to previously reported Q1 results and a consensus target range.
Market effects
Consumer staples relative-performance narrative may influence factor flows between defensives and broader benchmarks.
US-focused read-through via Dow-relative comparison; limited direct regional spillover described.
CL’s global revenue mix is referenced, but no new macro/geographic catalyst is introduced.
Alternative perspectives
The “underperforming the Dow” framing may be misleading because CL is still up YTD and trading above 50/200-day averages, suggesting the lag is more about benchmark strength than CL deterioration.
The article doesn’t quantify valuation, margin trajectory, or forward demand; without those, relative-performance conclusions may not translate into actionable near-term direction.
Key entities
- companyColgate-Palmolive Company
Subject of the article; discussed in terms of relative stock performance, technical trend, and prior Q1 2026 earnings beat.
- companyKimberly-Clark Corporation
Used as a peer comparison for 52-week and YTD performance; no separate news catalyst described.


%252Fsocialsamosa%252Fmedia%252Fmedia_files%252F2026%252F05%252F22%252Ffi-62-2026-05-22-18-54-07.png&w=3840&q=75)
&w=3840&q=75)
